Results for tag: "Vascular Malformation Drug"

The Vascular Malformation Drug market is a subset of the Cardiovascular Drugs market, which focuses on drugs used to treat vascular malformations. These malformations are abnormal connections between arteries and veins, which can cause a variety of symptoms, including pain, swelling, and bleeding. Vascular malformation drugs are used to reduce the symptoms and improve the patient's quality of life. These drugs can be administered orally, intravenously, or topically, depending on the severity of the malformation. Commonly used drugs include anticoagulants, antiplatelet agents, and vasodilators. Some companies in the Vascular Malformation Drug market include Pfizer, Novartis, Sanofi, and Bayer. Show Less Read more